Anna M Zemke,Leila R Zelnick,Ian H de Boer,Bryan Kestenbaum,Alan S Go,Nisha Bansal
{"title":"Accuracy of Identification of Cardiovascular Events with ICD Diagnosis Codes versus Physician Adjudication in CKD and Kidney Failure.","authors":"Anna M Zemke,Leila R Zelnick,Ian H de Boer,Bryan Kestenbaum,Alan S Go,Nisha Bansal","doi":"10.1681/asn.0000000874","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nThe risk of cardiovascular disease is elevated in individuals with chronic kidney disease (CKD), and cardiovascular disease events are common and important end-points for research studies in CKD. Adjudication by a central committee is considered the most rigorous approach of ascertaining cardiovascular disease outcomes, however, it is resource intensive. There are limited data to determine the accuracy of International Classification of Diseases (ICD) code-ascertained outcomes compared to physician-adjudication for cardiovascular disease events in CKD and kidney failure.\r\n\r\nMETHODS\r\nUsing data from the Chronic Renal Insufficiency Cohort, we evaluated hospitalization events in participants with CKD and kidney failure to determine accuracy of ICD-9 and 10 codes compared to physician-adjudication of the cardiovascular disease outcomes heart failure, myocardial infarction, stroke, and atrial fibrillation. For ICD codes, we determined the positive predictive value (PPV), negative predictive value (NPV), sensitivity and specificity for each cardiovascular disease outcome based on primary as well as secondary diagnosis codes. Association of known cardiovascular disease risk factors with incident cardiovascular disease outcomes were determined for ICD codes vs. physician-adjudication.\r\n\r\nRESULTS\r\nComparing primary ICD-9 or 10 discharge codes to physician-adjudication, for 3464 participants, we found PPVs of 79% for heart failure, 77% for myocardial infarction, 77% for ischemic stroke, and 85% for atrial fibrillation for individuals with CKD and kidney failure. NPVs ranged from 94% to 99%. Specificities were high at 99% to 100%. Sensitivities were much lower at 15% to 48%. The associations between cardiovascular disease risk factors and co-morbidities (including age, diabetes, eGFR) were similar for ICD code-identified and physician-adjudication identified events, with r-values ranging from 0.82 to 0.98.\r\n\r\nCONCLUSIONS\r\nPPV was near 80% for heart failure, myocardial infarction, stroke, and atrial fibrillation for primary ICD codes versus physician-adjudication, however sensitivity was lower. ICD code usage in medical research may allow greater efficiency with limited resources for outcome ascertainment.","PeriodicalId":17217,"journal":{"name":"Journal of The American Society of Nephrology","volume":"16 1","pages":""},"PeriodicalIF":9.4000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of The American Society of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1681/asn.0000000874","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND
The risk of cardiovascular disease is elevated in individuals with chronic kidney disease (CKD), and cardiovascular disease events are common and important end-points for research studies in CKD. Adjudication by a central committee is considered the most rigorous approach of ascertaining cardiovascular disease outcomes, however, it is resource intensive. There are limited data to determine the accuracy of International Classification of Diseases (ICD) code-ascertained outcomes compared to physician-adjudication for cardiovascular disease events in CKD and kidney failure.
METHODS
Using data from the Chronic Renal Insufficiency Cohort, we evaluated hospitalization events in participants with CKD and kidney failure to determine accuracy of ICD-9 and 10 codes compared to physician-adjudication of the cardiovascular disease outcomes heart failure, myocardial infarction, stroke, and atrial fibrillation. For ICD codes, we determined the positive predictive value (PPV), negative predictive value (NPV), sensitivity and specificity for each cardiovascular disease outcome based on primary as well as secondary diagnosis codes. Association of known cardiovascular disease risk factors with incident cardiovascular disease outcomes were determined for ICD codes vs. physician-adjudication.
RESULTS
Comparing primary ICD-9 or 10 discharge codes to physician-adjudication, for 3464 participants, we found PPVs of 79% for heart failure, 77% for myocardial infarction, 77% for ischemic stroke, and 85% for atrial fibrillation for individuals with CKD and kidney failure. NPVs ranged from 94% to 99%. Specificities were high at 99% to 100%. Sensitivities were much lower at 15% to 48%. The associations between cardiovascular disease risk factors and co-morbidities (including age, diabetes, eGFR) were similar for ICD code-identified and physician-adjudication identified events, with r-values ranging from 0.82 to 0.98.
CONCLUSIONS
PPV was near 80% for heart failure, myocardial infarction, stroke, and atrial fibrillation for primary ICD codes versus physician-adjudication, however sensitivity was lower. ICD code usage in medical research may allow greater efficiency with limited resources for outcome ascertainment.
期刊介绍:
The Journal of the American Society of Nephrology (JASN) stands as the preeminent kidney journal globally, offering an exceptional synthesis of cutting-edge basic research, clinical epidemiology, meta-analysis, and relevant editorial content. Representing a comprehensive resource, JASN encompasses clinical research, editorials distilling key findings, perspectives, and timely reviews.
Editorials are skillfully crafted to elucidate the essential insights of the parent article, while JASN actively encourages the submission of Letters to the Editor discussing recently published articles. The reviews featured in JASN are consistently erudite and comprehensive, providing thorough coverage of respective fields. Since its inception in July 1990, JASN has been a monthly publication.
JASN publishes original research reports and editorial content across a spectrum of basic and clinical science relevant to the broad discipline of nephrology. Topics covered include renal cell biology, developmental biology of the kidney, genetics of kidney disease, cell and transport physiology, hemodynamics and vascular regulation, mechanisms of blood pressure regulation, renal immunology, kidney pathology, pathophysiology of kidney diseases, nephrolithiasis, clinical nephrology (including dialysis and transplantation), and hypertension. Furthermore, articles addressing healthcare policy and care delivery issues relevant to nephrology are warmly welcomed.